Amdocs Ltd. Stock Plummets to New 52-Week Low of $63.53

Amdocs has reached a new 52-week low, trading at USD 63.53 as of March 20, 2026. This marks a significant decline for the small-cap company, which operates in the Computers - Software & Consulting industry. Over the past year, Amdocs has experienced a performance drop of 16.25%, contrasting sharply with the S&P 500's gain of 14.9%. Despite its challenges, Amdocs maintains a market capitalization of USD 17,662 million and exhibits a price-to-earnings (P/E) ratio of 28.00. The company has a relatively low debt-to-equity ratio of 0.17, indicating a conservative approach to leverage. Amdocs also boasts a return on equity (ROE) of 18.45%, reflecting efficient management. However, the company has faced difficulties in achieving long-term growth, with net sales increasing at an annual rate of just 1.68% over the past five years. Additionally, the stock has underperformed against the S&P 500 for three consecutive years, generating a return of -27.39% in the last year alone. As Amdocs navigates these trends, its recent price movement highlights the ongoing volatility in its market position.